10496389

Source:http://linkedlifedata.com/resource/pubmed/id/10496389

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0031740, umls-concept:C0205390, umls-concept:C0242383, umls-concept:C0376495, umls-concept:C0387288, umls-concept:C0600518, umls-concept:C1274040, umls-concept:C1314792, umls-concept:C2603343
pubmed:issue	9
pubmed:dateCreated	1999-9-24
pubmed:abstractText	To evaluate safety and short-term visual acuity and fluorescein angiographic effects of photodynamic therapy (PDT) after retreatments with verteporfin for choroidal neovascularization (CNV) in age-related macular degeneration (AMD) that demonstrated fluorescein leakage after at least 1 course of PDT.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/10496389, http://linkedlifedata.com/resource/pubmed/commentcorrection/10496389-10496388
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7706534
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Fluorescein, http://linkedlifedata.com/resource/pubmed/chemical/Photosensitizing Agents, http://linkedlifedata.com/resource/pubmed/chemical/Porphyrins, http://linkedlifedata.com/resource/pubmed/chemical/verteporfin
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	0003-9950
pubmed:author	pubmed-author:BarbazettoII, pubmed-author:BirngruberRR, pubmed-author:BresslerN MNM, pubmed-author:DonatiGG, pubmed-author:FsadniMM, pubmed-author:GragoudasE SES, pubmed-author:GrayTT, pubmed-author:LaneA MAM, pubmed-author:LaquaHH, pubmed-author:ManjurisUU, pubmed-author:MillerJ WJW, pubmed-author:PiguetBB, pubmed-author:PournarasC JCJ, pubmed-author:Schmidt-ErfurthUU, pubmed-author:SickenbergMM, pubmed-author:StrongH AHA, pubmed-author:ZografosLL, pubmed-author:van den BergHH
pubmed:issnType	Print
pubmed:volume	117
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1177-87
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:10496389-Aged, pubmed-meshheading:10496389-Aged, 80 and over, pubmed-meshheading:10496389-Capillary Permeability, pubmed-meshheading:10496389-Choroid, pubmed-meshheading:10496389-Choroidal Neovascularization, pubmed-meshheading:10496389-Female, pubmed-meshheading:10496389-Fluorescein, pubmed-meshheading:10496389-Fluorescein Angiography, pubmed-meshheading:10496389-Follow-Up Studies, pubmed-meshheading:10496389-Fundus Oculi, pubmed-meshheading:10496389-Humans, pubmed-meshheading:10496389-Macular Degeneration, pubmed-meshheading:10496389-Male, pubmed-meshheading:10496389-Middle Aged, pubmed-meshheading:10496389-Photochemotherapy, pubmed-meshheading:10496389-Photosensitizing Agents, pubmed-meshheading:10496389-Porphyrins, pubmed-meshheading:10496389-Retreatment, pubmed-meshheading:10496389-Safety, pubmed-meshheading:10496389-Treatment Outcome, pubmed-meshheading:10496389-Visual Acuity
pubmed:year	1999
pubmed:articleTitle	Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.
pubmed:affiliation	Retina Department, University Eye Hospital, Lübeck, Germany. uschmidterfurth@ophtha.mu-luebeck.de
pubmed:publicationType	Journal Article, Clinical Trial, Comment, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase II, Clinical Trial, Phase I